Phase I trial of topical XEN 402 ointment in volunteers.
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2010
At a glance
- Drugs Funapide (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Adverse reactions; Pharmacokinetics
- 17 Aug 2010 New trial record.
- 17 Aug 2010 Results reported in a Xenon Pharmaceuticals media release.